This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Clock restarts on Mérieux NutriSciences' Australian play for Bureau Veritas AsureQuality

( March 14, 2025, 07:38 GMT | Official Statement) -- MLex Summary: Food safety-testing services provider Mérieux NutriSciences’ bid to acquire 51 percent of Bureau Veritas AsureQuality is back on track in Australia, with the country's competition watchdog announcing it had received the additional information it had requested and had restarted the clock on its review. In a website entry, the Australian Competition & Consumer Commission set May 1 as the new preliminary deadline for an announcement, which could either see the deal cleared or the regulator progress to an in-depth investigation with the publication of a statement of issues. On Feb. 7, the watchdog announced it had stopped the clock on the deal, as it awaited further information. The original March 6 deadline was scrapped. The full entry on the Australian Competition & Consumer Commission's website follows: ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login